Xencor Inc XNCR
News
Xencor Announces Proposed Public Offering of Common Stock
Xencor Announces XmAb Drug Candidates in Autoimmune Disease with Near-Term Clinical Plans and Shares Clinical Progress in Early-Stage Oncology Programs
Xencor to Host Research & Development Webcast and Conference Call on Monday, September 9, 2024
Zenas BioPharma, Bicara Therapeutics sets IPO price ranges as summer lull ends
Xencor Reports Second Quarter 2024 Financial Results
Xencor: J&J's Janssen Termintates Rights to Plamotamab